43 research outputs found
Hypocalcémie post-thyroïdectomie
Introduction : LâhypocalcĂ©mie est la complication la plus prĂ©occupante de la thyroĂŻdectomie totale. Elle impose un traitement substitutif et un suivi Ă vie. Objectifs : Le but de cette Ă©tude est dâĂ©valuer lâincidence de lâhypocalcĂ©mie aprĂšs chirurgie et dâĂ©tudier sa corrĂ©lation avec les caractĂ©ristiques cliniques, biologiques et le type de chirurgie pratiquĂ©. MatĂ©riels et mĂ©thodes : Etude rĂ©trospective portant sur 488 cas de thyroĂŻdectomies, opĂ©rĂ©es entre 1992 et 1996. LâhypocalcĂ©mie est dĂ©finie par une calcĂ©mie infĂ©rieure Ă 80 mg/l «2 mmol/l ». Les patients, toujours dĂ©pendants dâun traitement substitutif un an aprĂšs la chirurgie, ont Ă©tĂ© considĂ©rĂ©s comme ayant une hypocalcĂ©mie dĂ©finitive. RĂ©sultats : Dans notre Ă©tude, 368 patients ont eu une thyroĂŻdectomie totale et 120 ont eu une thyroĂŻdectomie subtotale. Le goitre multinodulaire Ă©tait la pathologie la plus frĂ©quente, notĂ© dans 359 cas, suivie des cancers thyroĂŻdiens notĂ© dans 83 cas. LâhypocalcĂ©mie postopĂ©ratoire a Ă©tĂ© retrouvĂ©e chez 54 patients (11,06%) dont 25 Ă©taient asymptomatique. Cette hypocalcĂ©mie sâest rĂ©vĂ©lĂ©e dĂ©finitive chez 14 dâentre eux (2,8%). Nous nâavons pas trouvĂ© de corrĂ©lation statistiquement significative entre lâhypoparathyroĂŻdie dĂ©finitive et les caractĂ©ristiques cliniques biologiques et le type de chirurgie.Conclusion : Dans la plupart des cas, lâhypocalcĂ©mie est liĂ©e Ă un hypoparathyroĂŻdisme transitoire, secondaire au traumatisme ou Ă la dĂ©vascularisation des parathyroĂŻdes. LâhypoparathyroĂŻdie dĂ©finitive est rare, elle est toujours secondaire Ă une lĂ©sion irrĂ©versible des parathyroĂŻdes. Les caractĂ©ristiques cliniques initiales des patients et les examens biologiques prĂ©coces ne permettent pas de prĂ©dire lâĂ©volution.Mots-clĂ©s : ThyroĂŻde, chirurgie, hypocalcĂ©mie, parathyroĂŻde
Recidive tardive d'un sarcome a cellule claire
Introduction : The clear cell sarcoma (melanoma of soft tissue) is a rare tumor of young adults. Hi occur most commonly in the extremities. We report the case of a man of 70 years, with previous history of a malignant melanoma of the cervical trachea treated by radiotherapy, who present 18 years after Tracheo-esophageal tumor. The tumor was totally removed.Final pathologic diagnosis is a recurrence of his sarcoma cell clear. Three years later, the patient has no signs of recurrence. The aim of this work is to study the clinical features, the prognosis of these cancers and the modality of her treatments.Keywords: the clear cell sarcoma, melanoma of soft tissue, radiotherapy, surgery
A highly efficient green synthesis of 1, 8-dioxo-octahydroxanthenes
SmCl3 (20 mol%) has been used as an efficient catalyst for reaction between aromatic aldehydes and 5,5-dimethyl-1,3-cyclohexanedione at 120°C to give 1,8-dioxo-octahydroxanthene derivatives in high yield. The same reaction in water, at room temperature gave only the open chain analogue of 1,8-dioxo-octahydroxanthene. Use of eco-friendly green Lewis acid, readily available catalyst and easy isolation of the product makes this a convenient method for the synthesis of either of the products
Cross-national variations in reported discrimination among people treated for major depression worldwide: The ASPEN/INDIGO international study
Background: No study has so far explored differences in discrimination reported by people with major depressive disorder (MDD) across countries and cultures. Aims: To (a) compare reported discrimination across different countries, and (b) explore the relative weight of individual and contextual factors in explaining levels of reported discrimination in people with MDD. Method: Cross-sectional multisite international survey (34 countries worldwide) of 1082 people with MDD. Experienced and anticipated discrimination were assessed by the Discrimination and Stigma Scale (DISC). Countries were classified according to their rating on the Human Development Index (HDI). Multilevel negative binomial and Poisson models were used. Results: People living in 'very high HDI' countries reported higher discrimination than those in 'medium/low HDI' countries. Variation in reported discrimination across countries was only partially explained by individual-level variables. The contribution of country-level variables was significant for anticipated discrimination only. Conclusions: Contextual factors play an important role in anticipated discrimination. Country-specific interventions should be implemented to prevent discrimination towards people with MDD
Grand Challenges in global eye health: a global prioritisation process using Delphi method
Background: We undertook a Grand Challenges in Global Eye Health prioritisation exercise to identify the key issues that must be addressed to improve eye health in the context of an ageing population, to eliminate persistent inequities in health-care access, and to mitigate widespread resource limitations. Methods: Drawing on methods used in previous Grand Challenges studies, we used a multi-step recruitment strategy to assemble a diverse panel of individuals from a range of disciplines relevant to global eye health from all regions globally to participate in a three-round, online, Delphi-like, prioritisation process to nominate and rank challenges in global eye health. Through this process, we developed both global and regional priority lists. Findings: Between Sept 1 and Dec 12, 2019, 470 individuals complete round 1 of the process, of whom 336 completed all three rounds (round 2 between Feb 26 and March 18, 2020, and round 3 between April 2 and April 25, 2020) 156 (46%) of 336 were women, 180 (54%) were men. The proportion of participants who worked in each region ranged from 104 (31%) in sub-Saharan Africa to 21 (6%) in central Europe, eastern Europe, and in central Asia. Of 85 unique challenges identified after round 1, 16 challenges were prioritised at the global level; six focused on detection and treatment of conditions (cataract, refractive error, glaucoma, diabetic retinopathy, services for children and screening for early detection), two focused on addressing shortages in human resource capacity, five on other health service and policy factors (including strengthening policies, integration, health information systems, and budget allocation), and three on improving access to care and promoting equity. Interpretation: This list of Grand Challenges serves as a starting point for immediate action by funders to guide investment in research and innovation in eye health. It challenges researchers, clinicians, and policy makers to build collaborations to address specific challenges. Funding: The Queen Elizabeth Diamond Jubilee Trust, Moorfields Eye Charity, National Institute for Health Research Moorfields Biomedical Research Centre, Wellcome Trust, Sightsavers, The Fred Hollows Foundation, The Seva Foundation, British Council for the Prevention of Blindness, and Christian Blind Mission. Translations: For the French, Spanish, Chinese, Portuguese, Arabic and Persian translations of the abstract see Supplementary Materials section
Grand Challenges in global eye health: a global prioritisation process using Delphi method
Background
We undertook a Grand Challenges in Global Eye Health prioritisation exercise to identify the key issues that must be addressed to improve eye health in the context of an ageing population, to eliminate persistent inequities in health-care access, and to mitigate widespread resource limitations.
Methods
Drawing on methods used in previous Grand Challenges studies, we used a multi-step recruitment strategy to assemble a diverse panel of individuals from a range of disciplines relevant to global eye health from all regions globally to participate in a three-round, online, Delphi-like, prioritisation process to nominate and rank challenges in global eye health. Through this process, we developed both global and regional priority lists.
Findings
Between Sept 1 and Dec 12, 2019, 470 individuals complete round 1 of the process, of whom 336 completed all three rounds (round 2 between Feb 26 and March 18, 2020, and round 3 between April 2 and April 25, 2020) 156 (46%) of 336 were women, 180 (54%) were men. The proportion of participants who worked in each region ranged from 104 (31%) in sub-Saharan Africa to 21 (6%) in central Europe, eastern Europe, and in central Asia. Of 85 unique challenges identified after round 1, 16 challenges were prioritised at the global level; six focused on detection and treatment of conditions (cataract, refractive error, glaucoma, diabetic retinopathy, services for children and screening for early detection), two focused on addressing shortages in human resource capacity, five on other health service and policy factors (including strengthening policies, integration, health information systems, and budget allocation), and three on improving access to care and promoting equity.
Interpretation
This list of Grand Challenges serves as a starting point for immediate action by funders to guide investment in research and innovation in eye health. It challenges researchers, clinicians, and policy makers to build collaborations to address specific challenge
Effect of Al2O3 decoration on the opto-electrical properties of a porous Si/Cr2O3 composite
In this work, we present an extensive investigation of the effect of AlâOâ decoration on the morphological, structural and opto-electronic properties of a porous Si (Sip)/CrâOâ composite. The Sip layers were prepared by the anodization method. AlâOâ and CrâOâ thin films were deposited by physical vapour deposition. The morphological and micro-structural properties of Sip/CrâOâ/AlâOâ were studied using the scanning electron microscope, energy dispersive X-ray spectroscopy and X-ray diffraction techniques. It was found that AlâOâ decoration with different concentration strongly affects the Sip/CrâOâ microstructure mainly at the level of porosity. Variable angle spectroscopic ellipsometry demonstrates a strong correlation between optical constants (n and k) of Sip/CrâOâ/AlâOâ and microstructure properties. Dielectric properties of Sip/CrâOâ/AlâOâ such as electrical conductivity and conduction mechanism were explored using impedance spectroscopy over the temperature interval ranging from 340 to 410°C. A semiconductor to the metallic transition has been observed at high frequency
Several Aspects of Information Flows in PLM
Part 1: Knowledge ManagementInternational audienceThere are lots of activities in the product lifecycle, which are grouped into three main phases: beginning of life (BOL), middle of life (MOL), and end of life (EOL). Thanks to recent emerging technologies, information flows of whole product lifecycle can be visible and controllable. The PLM under this environment allows all actors of the whole product lifecycle to access, manage, and control information flows. These flows can be used to streamline several operations of BOL, MOL and EOL. In order to recognize the benefit of these information flows, first of all, it is necessary to comprehend them in detail. For this purpose, this study will deal with several aspects of information flows in PLM. It will clarify the concept of information flows and identify which product lifecycle information are required for streamlining lifecycle operations, and classify them into several types depending on their characteristics
Angiomyxome agressif de la joue : a propos dâune observation
Lâangiomyxome agressif est une tumeur mĂ©senchymateuse dĂ©veloppĂ©e aux dĂ©pens du tissu conjonctif avec un site de prĂ©dilection pour les parties molles du pĂ©rinĂ© fĂ©minin. Cette tumeur croit progressivement mais nâest pas mĂ©tastatique. Le traitement indiquĂ© actuellement est lâexĂ©rĂšse chirurgicale large sans consĂ©quences fonctionnelles lourdes. La tumeur a une tendance Ă la rĂ©cidive locale, qui est frĂ©quente, liĂ©e Ă la difficultĂ© dâune exĂ©rĂšse initiale complĂšte. Les auteurs rapportent ici le cas dâun angiomyxome agressif de la joue, qui a Ă©tĂ© traitĂ© par chirurgie et chimiothĂ©rapie. Les aspects cliniques, histologiques et thĂ©rapeutiques de la tumeur ont Ă©tĂ© discutĂ©s.Mots-clĂ©s : Lâangiomyxome agressif, tumeur mĂ©senchymateuse, exĂ©rĂšse, rĂ©cidive